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A B S T R A C T   
Perfluoroalkyl acids (PFAAs) are persistent man-made chemicals, ubiquitous in nature and present in human 
samples. Although restrictions are being introduced, they are still used in industrial processes as well as in 
consumer products. PFAAs cross the blood-brain-barrier and have been observed to induce adverse neuro-
behavioural effects in humans and animals as well as adverse effects in neuronal in vitro studies. The sulfonated 
PFAA perfluorooctane sulfonic acid (PFOS), has been shown to induce excitotoxicity via the N-methyl-D- 
aspartate receptor (NMDA-R) in cultures of rat cerebellar granule neurons (CGNs). In the present study the aim 
was to further characterise PFOS-induced toxicity (1–60 μM) in rat CGNs, by examining interactions between 
PFOS and elements of glutamatergic signalling and excitotoxicity. Effects of the carboxylated PFAA, per-
fluorooctanoic acid (PFOA, 300–500 μM) on the same endpoints were also examined. During experiments in 
immature cultures at days in vitro (DIV) 8, PFOS increased both the potency and efficacy of glutamate, whereas 
in mature cultures at DIV 14 only increased potency was observed. PFOA also increased potency at DIV 14. PFOS- 
enhanced glutamate toxicity was further antagonised by the competitive NMDA-R antagonist 3-((R)-2-Carbox-
ypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) at DIV 8. At DIV 8, PFOS also induced glutamate release (9–13 
fold increase vs DMSO control) after 1− 3 and 24 h exposure, whereas for PFOA a large (80 fold) increase was 
observed, but only after 24 h. PFOS and PFOA both also increased alanine and decreased serine levels after 24 h 
exposure. In conclusion, our results indicate that PFOS at concentrations relevant in an occupational setting, may 
be inducing excitotoxicity, and potentiation of glutamate signalling, via an allosteric action on the NMDA-R or by 
actions on other elements regulating glutamate release or NMDA-R function. Our results further support our 
previous findings that PFOS and PFOA at equipotent concentrations induce toxicity via different mechanisms of 
action.   
1. Introduction 
Perfluorinated compounds such as the perfluoroalkyl acids (PFAAs) 
are molecules composed of a fully fluorinated carbon chain attached to a 
functional group. The C–F bonds of the PFAAs are extremely stable, thus 
making the molecule resistant to degradation, and results in the accu-
mulation of these compounds in the environment as well as in living 
organisms (Buck et al., 2011). Two such compounds, that have been a 
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focus of attention over the two last decades, are the sulfonated per-
fluorooctane sulfonic acid (PFOS) and the carboxylated per-
fluorooctanoic acid (PFOA). Although the use of these compounds has 
diminished in many parts of the world over the last years due to 
increasing evidence of their toxic properties, and ban through the 
Stockholm Convention, they are still produced in several countries 
(UNEP, 2020). PFOS is currently still used in firefighting foam, hydraulic 
fluids, textiles, electric and electronic parts, and in applications like 
photo imaging. PFOA is used for the production of non-stick cookware 
and food processing equipment, and PFOA-related compounds that 
degrade to PFOA are used as surfactants and as surface treatment of 
paper and textiles as well as in paints (UNEP, 2020). Due to past and 
current uses, PFOS and PFOA are found at quite high levels in human 
blood where they bind to plasma proteins. They also cross the 
blood-brain barrier, and have been detected in the brain of the devel-
oping foetus (Mamsen et al., 2019). 
Many studies in vivo and in vitro show that PFOS and PFOA may 
have adverse effects on various organ systems, including the nervous 
system. Exposure studies of neonatal mice to PFOS and PFOA showed 
effects on proteins important for neuronal growth and synaptogenesis in 
the developing brain, and neurobehavioural effects in adults (Johansson 
et al., 2008, 2009). Further, daily exposure of adult mice to PFOS in 
another study, resulted in neurotoxic effects on the hippocampus, fol-
lowed by impairment of spatial learning and memory (Long et al., 
2013). Epidemiological studies have shown that prenatal exposure to 
PFOS and PFOA may be associated with an effect on neurodevelopment 
and increase hyperactivity in children (Hoyer et al., 2015), and in a 
recent study an association was found between early life exposure to 
PFOS and ADHD (Lenters et al., 2019). Prenatal exposure to PFOS was 
also adversely associated with gross motor development in 2-year-old 
children (Chen et al., 2013), as well as executive function deficits in 
school-age children (Vuong et al., 2016). 
In previous studies of PFAAs in rat cerebellar granule neurons 
(CGNs) we observed that when perfluorinated molecules with the same 
total number of carbon atoms in the chain are attached to a sulfonate 
group as compared to a carboxyl group, the toxicity of the molecule was 
markedly increased (Berntsen et al., 2017). PFOS and PFOA both 
contain 8 carbon atoms in their molecular formula, but whereas PFOS is 
attached to a sulfonate group, PFOA contains a head carboxyl group 
(Fig. 1). When equipotent concentrations of PFOS and PFOA were used, 
PFOS induced maximum toxicity after 1 h of exposure, whereas the 
toxicity induced by PFOA was much slower, and maximum toxicity was 
reached after 24 h, the latest time-point studied (Berntsen et al., 2017). 
We further found that PFOS, but not PFOA caused an increase in 
intracellular calcium, which was completely blocked by pre-treatment 
with the N-methyl-D-aspartate receptor (NMDA-R) antagonist MK-801. 
Blocking of the NMDA-R using either competitive (CPP) or 
non-competitive (MK-801) NMDA-R antagonists, as well as chelation of 
extracellular calcium (EGTA), protected against PFOS-, but not 
PFOA-induced toxicity in immature cultures at days in vitro (DIV) 8. 
Protection against PFOS, and to some extent PFOA toxicity, was also 
afforded in mature cultures at DIV 14 by NMDA-R antagonists (Berntsen 
et al., 2018). 
Effects of toxicants on the NMDA-R may be induced by direct action 
on the receptor itself, or by secondary processes such as release of 
glutamate from the cells or inhibition of glutamate re-uptake by gluta-
mate transporters (Reistad et al., 2007). The aim of the current study 
was, therefore, to identify whether PFOS-induced cytotoxicity is due to 
direct actions on the glutamate receptor, or whether other possible 
mechanisms such as PFOS-induced glutamate (or other amino acids 
involved in neuronal function) release are involved. For consistency 
with our previous work PFOA was also included in these studies. 
2. Materials and methods 
2.1. Chemicals and reagents 
Acetonitrile (HPLC-grade), albumin from bovine serum (BSA, ≥ 96 
%), amino acid standards and internal standard norvaline for UHPLC- 
PDA, cytosine β-D-arabinofuranoside (ARA-C), deoxyribonuclease I 
from bovine pancreas (DNAse), dimethyl sulfoxide (DMSO, ≥ 99.9 %), L- 
glutamic acid monosodium salt hydrate (glutamate ≥ 99 %), glycine, 
perfluorooctanesulfonic acid potassium salt (PFOS ≥ 98 %, CAS Num-
ber: 2795− 39-3), perfluorooctanoic acid (PFOA, 96 %, CAS Number: 
335− 67-1), poly-L-lysine hydrobromide (Mw > 70,000 g/mol), 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), trypsin 
(type I) from bovine pancreas and trypsin inhibitor from glycine max 
(soybean type I–S) were purchased from Sigma-Aldrich, St. Louis, MO, 
USA. Basal medium Eagle (BME), heat inactivated foetal bovine serum 
(FBS), Glutamax-I supplement – 200 mM, Hanks’ Balanced Salt Solution 
(HBSS) – 10X, HEPES buffer – 1 M and penicillin (100 IU/mL)- 
streptomycin (100 μg/mL) were obtained from GIBCO/Invitrogen, 
Norway. 3-((R)-2-Carboxypiperazin-4-yl)-propyl-1-phosphonic acid 
(CPP, ≥ 98 %) was purchased from Tocris Biosciences (Bristol, UK). The 
AccQ-Tag Ultra eluent A and AccQ-Tag Ultra derivatisation kit were 
acquired from Waters Corporation (Milford, MA, USA). Ultrapure water 
was produced from a RiOs 100 Milli-Q purification system from Merck 
Millipore (Billerica, MA, USA). 
All other chemicals and reagents used were obtained from standard 
commercial suppliers. Stock solutions of PFOS and PFOA were prepared 
by dissolution in DMSO, whereas glutamate and glycine were dissolved 
in Milli-Q-water. The stocks were frozen and thawed between experi-
ments to ensure the use of the same stocks for all experiments. 
2.2. Laboratory animals 
For each isolation of cells, mixed-sex litters of 10 Wistar rat pups 
were obtained at 8 days of age from Taconic, Denmark. The pups were 
euthanised, by a veterinarian with FELASA C certification, without prior 
Fig. 1. Chemical structures with molecular formula for PFOS (Mw =538.2 Da) 
and PFOA (Mw =414.1 Da). 
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use of anaesthesia, by decapitation on the day of arrival, at the Animal 
Laboratory Unit at the Section of Experimental Biomedicine, Norwegian 
University of life Sciences. The animal facility is licensed by the Nor-
wegian Food Safety Authority (https://www.mattilsynet.no/language 
/english/) and accredited by the Association for Assessment and 
Accreditation of Laboratory Animal Care (https://www.aaalac.org/). 
All procedures were in accordance with the Norwegian Animal Welfare 
Act and the Directive 2010/63/EU of the European Parliament and of 
the Council on the protection of animals used for scientific purposes. 
Efforts were made to minimise animal suffering and to reduce the 
number of animals used. 
2.3. Isolation of rat cerebellar granule neurons 
Primary cultures of post-mitotic CGNs from rat pups at postnatal day 
(PND) 8, were prepared as described in Berntsen et al. (2013), with 
modifications from Mariussen et al. (2002), based on the procedures 
originally described in Schousboe et al. (1989) and Gallo et al. (1982). 
Cells from each isolation were diluted to an approximate concentration 
of 1–1.2 × 106 cells/mL in BME, supplemented with 10 % 
heat-inactivated FBS, 2.5 mM Glutamax, 100 IU/mL penicillin + 100 
μg/ml streptomycin, 25 mM KCl and 1 % glucose, and transferred to 12 
well poly-L-lysine treated (0.01 mg/mL for 2 h, 1 mL per well) cell 
culture plates (Nunc, 1 mL cells per well). The cytostatic drug ARA-C 
was added to all plates after 24 h - at DIV 1, giving a concentration of 
10.3 μM in the cell medium, to prevent the replication of non-neuronal 
cells. That cultures consisted mainly of granule cells was confirmed 
during each experiment by phase contrast microscopy, but the per-
centage of remaining glial cells was not specifically assessed by staining 
in the present study. This has, however, been extensively reported by 
others, and primary cultures of CGNs at DIV 8 are typically found to 
contain around 97 % neuronal cells when the cytostatic drug ARA-C is 
added to the culture medium at DIV 1, as in the present study. 
Approximately 5 % of the cells will be GABAergic basket or Golgi neu-
rons, whereas the number of astrocytes would be < 3% (Nicoletti et al., 
1986; Perez-Gomez et al., 2004). After the addition of ARA-C, cultures to 
be treated on DIV 8–9 were left undisturbed in a CO2 incubator without 
medium change, at 36 ◦C and 5 % CO2. For CGN-cultures left until DIV 
14 additional glucose (1 mg/mL) was also added to the medium on DIV 
7, 9 and 12 as previously described by de Luca et al. (1996). For all 
chemical treatments, CGNs were exposed to toxicants in BME supple-
mented with 2.5 mM Glutamax, 100 IU/mL penicillin + 100 μg/ml 
streptomycin, 25 mM KCl and 1 % glucose, without FBS, with the 
exception of the measurements of extracellular concentrations of amino 
acids, where cells were exposed in supplemented HBSS buffer (pH 7.4) 
(containing 20 mM HEPES, 4.17 mM NaHCO3, 5 mM glucose and 25 mM 
KCl). All exposures were performed in triplicate, and a mean value 
calculated for each concentration. Each experiment was repeated 
several times in separately-prepared cultures with cells from each 
isolation counted as one independent replicate. 
2.4. Exposure of CGNs and assessment of cell viability 
2.4.1. Glutamate concentration-response curves and effects of PFOS and 
PFOA 
On DIV 8 CGNs were exposed to one of 6 concentrations of glutamate 
(1, 10, 20, 100, 250 or 500 μM) in conjunction with 5 μM glycine to 
establish a glutamate concentration-response curve. Additionally, cells 
were exposed to glutamate in conjunction with various concentrations 
of PFOS or PFOA (or to the toxicants alone) to examine their effect on 
glutamate-induced cytotoxicity (n = 3–6). The concentrations of PFOS 
(20 and 40 μM) and PFOA (300 and 450 μM) used in the initial studies 
were based on previous studies (Berntsen et al., 2017, 2018) and were 
aimed at inducing little or no toxicity on their own. Additional experi-
ments using lower non-toxic concentrations (1 and 10 μM PFOS, and 10 
μM PFOA) were thereafter conducted to establish whether observed 
effects were concentration dependent. To examine effects of glutamate 
in combination with PFOS and PFOA in cells expressing mature NMDA 
receptors, experiments were repeated on CGNs at DIV 14 using the same 
6 concentrations of glutamate + 5 μM glycine or 1, 10, 20 and 100 μM 
glutamate + 5 μM glycine in conjunction with 20 μM PFOS or 300 μM 
PFOA. PFOS and PFOA was also tested alone (n = 4 for all). The ability of 
the competitive NMDA-R antagonist CPP (10 μM) to protect against 
glutamate + glycine toxicity alone and in conjunction with 20 μM PFOS 
or 300 μM PFOA was also tested in cells at DIV 8 (n = 4 for all). In our 
experiments the applied concentrations of PFOS were lower, whereas 
the concentrations of PFOA were higher, than levels reported in occu-
pationally exposed workers by Fu et al. (2016), where serum levels up to 
236 and 77 μM of the two compounds respectively, were detected. 
2.4.2. The MTT assay 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) assay is based on the cleavage of the yellow tetrazolium salt MTT 
into the blue product formazan by the mitochondrial enzyme succinate 
dehydrogenase in living cells (Mosmann, 1983). In the assay, a decrease 
in the number of living cells results in a reduction of the amount of 
formazan produced compared to the control, and indicates the degree of 
cytotoxicity. The assay was executed as described in Berntsen et al. 
(2013). Dual wavelength absorbance measurements were performed at 
570 and 690 nm in a VICTOR3 multilabel reader (PerkinElmer, Inc. 
Waltham, MA, USA). 
2.5. Measurement of extracellular glutamate and other amino acids at 
various time-points 
To measure the release of glutamate or other amino acids from the 
cells to the extracellular environment, CGNs were exposed in supple-
mented HBSS buffer to PFOS (60 μM), PFOA (500 μM) or DMSO (0.1 %) 
for 10 or 30 min, as well as 1, 2, 3 and 24 h. The supernatant was then 
removed and stored at - 20 ◦C until analysis with UHPLC-PDA (n = 3). 
The concentrations of the PFAAs were chosen based on a previous study, 
where time curves for toxicity were established for the same time-points 
using concentrations inducing equipotent effects after 24 h exposure 
(Berntsen et al., 2017). 
2.5.1. Sample preparation and AccQ-Tag derivatisation method for amino 
acid analysis 
Amino acid derivatisation with AccQ-tag reagents was conducted 
according to the manufacturer’s protocol. Briefly, 10 μL of the amino 
acid containing solution was mixed with 70 μL of AccQ-Tag borate 
buffer and 20 μL of AccQ-Tag reagent solution. The reaction was allowed 
to proceed for 10 min at 55 ◦C. The amino acids included in the analysis 
were: serine, arginine, glycine, aspartic acid, glutamate, threonine, 
alanine, proline, cysteine, lysine, tyroxine, methionine, valine, isoleu-
cine, leucine and phenylalanine. As an internal standard (IS) for quan-
titative determination of the analytes, a structural isomer of valine, 
norvaline, was chosen. Norvaline is an excellent IS for the analysis of 
amino acids as it has similar properties but does not interfere with the 
analysis. Norvaline was added at a concentration of 100 μM. 
2.5.2. Amino acid analysis by UHPLC-PDA 
A water Acquity UHPLC system equipped with a binary solvent 
manager, an autosampler and a column heater fitted with a PDA de-
tector was used for amino acid analysis. Chromatographic separation 
was achieved using an Acquity UPLC BEH C18 column (2.1 × 100 mm, 
1.7 μm) heated at 43 ◦C. Mobile phase A and B were 10 % AccQ-Tag 
Ultra concentrate eluent A and 100 % of pure acetonitrile, respec-
tively. The mobile phase flow was maintained at 0.4 mL/min during the 
analysis. Gradient elution was achieved as follows: 0− 0.54 min 99.9 % 
solvent A, 5.74 min 90.0 % solvent A, 7.74 min 78.8 % solvent A, 
8.04–8.64 min 40.4 % solvent A, 8.73− 10 min 99.9 % solvent A. The 
PDA detector was set at 260 nm, with a sampling rate of 20 points/min. 
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The performance of the UHPLC-PDA method for the analysis was 
evaluated by determining important method characteristics such as 
reproducibility, linearity and selectivity in the analysis. Method 
repeatability (intra-day variability) in terms of RSD (%) was found to be 
< 2.6 % for all the analytes, while method reproducibility, measured 
over a three week period, was found to be < 3.6 % also in terms of RSD 
(%), for all analytes included in the analysis. Method linearity was 
confirmed in the range of concentrations from 25 to 200 μM, with cor-
relation coefficients (R2) better than 0.989 and homoscedasticity in re-
sidual analysis. The method selectivity was appropriate as no 
interferences were observed in the chromatograms of standard solutions 
made in the matrix, matrix blanks or the real samples (Supplementary 
Figure S1-S4). The limit of quantification (LOQ) was 25 μM for all 
analytes. No limit of detection (LOD) was determined as it was not 
necessary for the purpose of the study. In the case of the amino acids 
glutamate and glycine, where the chromatographic relative signal 
response area were under LOQ levels, relative signal response area was 
used as a qualitative measurement of changes in amino acid concen-
trations (Fig. 5 A and B). 
2.6. Statistical analysis 
For the studies of effects of PFOS/PFOA and CPP treatment on the 
glutamate concentration-response curve, as well as amino acid mea-
surements at different time-points, significant differences were tested 
using a two-way ANOVA, with a Tukey-Kramer post hoc test. In all the 
experiments conducted, a p-value of < 0.05 was regarded as statistically 
significant. Best fit concentration-response curves for estimation and 
comparison of EC50 values and curves after exposure to glutamate +
glycine alone or in conjunction with PFOA/PFOS were obtained by non- 
linear regression in PRISM 7, using a 3-parameter model with constant 
Hill-slope of -1. Concentrations were log transformed prior to analysis. 
To obtain valid confidence intervals for the EC50 values at DIV 14 bot-
tom values of the model were constrained to a common value. 
3. Results 
3.1. Effects of PFAA exposure on the glutamate concentration-response 
curve 
3.1.1. Glutamate concentration-response curves at DIV 8 
Exposure of CGNs at DIV 8 to 1, 10, 20, 100, 250 and 500 μM 
glutamate in conjunction with 5 μM glycine resulted in a concentration- 
response curve for glutamate running from 100 % viability to between 
40–60 % viability, dependent on the different experimental runs. 
Maximum toxicity was observed at a concentration of 100 μM gluta-
mate, and no further increases in toxicity were observed at doses of 250 
and 500 μM (Fig. 2). 
Effects of co-incubation with PFOS and PFOA on the glutamate 
concentration-response curve were tested at DIV 8. The application of a 
non-toxic (20 μM) and marginally toxic (40 μM) concentration of PFOS 
caused a significant potentiation of glutamate-induced toxicity and 
shifted the glutamate concentration-response curve both down and to 
the left. EC50 values were significantly different when the values for the 
curves of glutamate + glycine + 20 μM PFOS (EC50 2.4 μM) and gluta-
mate + glycine + 40 μM PFOS (EC50 5.2 μM) were compared to the 
values for the curves of glutamate + glycine controls (EC50 9.3 μM) (3- 
parameter model, p = 0.04). Mean viability of cells after treatment with 
20 and 40 μM PFOS only was 108 and 82 %, respectively. In a second 
experimental run, 1 and 10 μM PFOS were tested alone and together 
with glutamate + glycine, however application of these concentrations 
induced no significant changes to the EC50 values. Viability after expo-
sure to 1 and 10 μM PFOS was 99 and 110 % of the DMSO control, 
respectively. 
For co-exposure of CGNs to PFOA at DIV 8, concentrations of 300 and 
450 μM PFOA were used. However, 450 μM PFOA reduced CGN viability 
to 40 %, so only the combined results after co-incubation with 300 μM 
PFOA were included in further analysis. PFOA (300 μM) on its own 
reduced viability to 78 %, but caused no significant changes to the 
glutamate + glycine EC50 values when co-applied with glutamate +
glycine. When a lower concentration of PFOA was used (10 μM), this did 
neither have a significant effect on viability (98 % of the DMSO control), 
nor did it cause a significant alteration of the glutamate + glycine EC50 
value, when co-applied. 
When the curve for all experiments of glutamate + glycine was 
compared to the curves of glutamate + glycine in conjunction with 1, 10, 
20 or 40 μM PFOS or 10 or 300 μM PFOA, the curves were found to be 
statistically significantly different (p < 0.0001). The curves for PFOS and 
PFOA are plotted separately in Fig. 2 A and B for illustrative purposes. 
EC50 values with 95 % CI for all the curves are presented in Supple-
mentary Table S1. 
3.1.2. Glutamate concentration-response curves at DIV 14 
In cells expressing mature NMDA-receptors exposed at DIV 14, 
maximum toxicity after glutamate exposure was observed after treat-
ment with 100 μM glutamate + 5 μM glycine (Fig. 3). No further in-
creases were observed in toxicity at concentrations of 250 and 500 μM 
glutamate. Because of this, co-exposures of cells to glutamate in 
Fig. 2. Effects of PFOS and PFOA on the glutamate concentration-response 
curve in rat cerebellar granule neurons (CGNs) at days in vitro (DIV) 8. CGNs 
were exposed for 24 h to increasing concentrations of glutamate (1, 10, 20, 100, 
250 or 500 μM) with 5 μM glycine alone or in conjunction with A) PFOS (1, 10, 
20 or 40 μM) or B) PFOA (10 or 300 μM), before assessment of viability with the 
MTT assay (n = 3-10). The curve for glutamate + glycine is presented twice in A 
and B for illustrative purposes. Abbreviations: Glu = Glutamate. 
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conjunction with PFOS and PFOA, were only conducted at concentra-
tions of 1, 10, 20 and 100 μM glutamate. 
At DIV 14 exposure to 20 μM PFOS or 300 μM PFOA did not result in 
any significant toxicity (viability 116 and 94 % of the 0.1 % DMSO 
control, respectively). Co-incubation of CGNs to glutamate + glycine in 
conjunction with PFOS or PFOA, mainly resulted in a parallel left shift of 
the concentration-response curve (Fig. 3). In addition, PFOA also 
potentiated toxicity at the lowest glutamate concentration tested (1 μM) 
(Fig. 3). When the curves for glutamate + glycine, glutamate + glycine 
+ 20 μM PFOS and glutamate + glycine + 300 μM PFOA were compared 
these were found to be significantly different (p < 0.0001) as were the 
EC50 values (p < 0.01) (Fig. 3). The EC50 values with 95 % CI for the 
curves are presented in Table 1. 
3.2. Effects of CPP on the glutamate + glycine concentration-response 
curve 
The ability of 10 μM CPP to protect against glutamate + glycine 
toxicity alone and in conjunction with 20 μM PFOS or 300 μM PFOA was 
also tested in cells at DIV 8 (Fig. 4A–F). A 2-way ANOVA with glutamate 
concentration and additional treatment (PFOS, PFOA, PFOS + CPP, 
PFOA + CPP, no additional treatment, and CPP only) as independent 
variables showed significant interaction between the effects of gluta-
mate concentration and additional treatments on cell viability (F25,108 =
5.104, p < 0.0001). Simple main effect analysis showed that both 
glutamate concentration and additional treatment had significant effects 
on cell viability (F5,108 = 16.65, p < 0.0001) and (F5,108 = 96.25, p < 
0.0001), respectively. CPP significantly antagonised glutamate/glycine 
at the 3 highest concentrations (p < 0.001 for the lower and p < 0.01 for 
the highest) and significantly reduced the toxicity of combined 
glutamate/glycine and PFOS from a glutamate concentration of 10 μM 
and above (p < 0.001 for all) (Fig. 4). At 10 μM and above there were 
also significant differences between the toxicity induced by glutamate +
glycine only, and glutamate + glycine in combination with PFOS (p <
0.05 at 100 μM, < 0.01 at 250 μM and < 0.001 at 10, 20 and 500 μM), 
indicating that PFOS added to the toxicity already induced by glutamate 
+ glycine, as previously observed. Significant antagonism by CPP was 
also observed at concentrations of glutamate from 100 μM and above in 
combination with PFOA (p < 0.05 at 250 and 500 μM and < 0.01 at 100 
μM). There was however no difference between the toxicity induced by 
glutamate + glycine and glutamate + glycine + PFOA at these con-
centrations, indicating that PFOA did not add to the glutamate toxicity 
under these conditions, and that the effect of CPP was likely due to 
antagonism of the glutamate-induced toxicity only. Mean cell viability 
for PFOS and PFOA only in the same experiments was 103 and 88 % of 
the DMSO control, respectively. 
3.3. Measurement of time-dependent release of amino acids to the 
extracellular space 
The release of amino acids from CGNs to the extracellular environ-
ment, after exposure to PFOS or PFOA (or control solutions) was 
measured by UHPLC-PDA in samples of supernatant removed after 10 
and 30 min, as well as 1, 2, 3 and 24 h of exposure. Of the 16 amino acids 
included in the analysis only alanine and serine were detected above the 
limit of quantification (LOQ). For glutamate (Fig. 5A) and glycine 
(Fig. 5B) the levels measured were below the validated LOQ and results 
are therefore presented as signal response area (au) relative to the area 
of the IS norvaline. The concentrations of alanine and serine are shown 
in Fig. 5C and D. Due to poor quality of one sample series, only the re-
sults from 2 experiments were used. When results were analysed sta-
tistically using 2-way ANOVA there was a significant interaction of time 
and exposure on glutamate concentration (F15,23 = 7.003, p < 0.001), 
and both time (F5,23 = 6.64, p < 0.001) and exposure (F3,23 = 8.21, p < 
0.001) also had significant influence on glutamate release. After multi-
ple comparisons, however, only after 24 h was a significant difference 
detected between PFOA and the 0.1 % DMSO control, where an 80 fold 
increase was observed (p < 0.001) (Fig. 5A). There were small increases 
in glutamate concentrations after PFOS exposure compared to the 0.1 % 
DMSO control at the earlier exposure times as well as after 24 h (2 fold 
increase after 10 min, 4 fold increase after 30 min, 9 fold increase after 1 
and 24 h, and 13 fold increase after 2 and 3 h), however these differences 
were not statistically significant. For glycine there was no significant 
interaction detected between the effects of time and treatment on con-
centration (2-way ANOVA). Likewise, there was no effect of treatment. 
Time however, did have a significant effect on concentration. When 
glycine levels at 24 h were compared to all earlier time-points, there was 
a significant increase observed for all the four treatment groups 
(Fig. 5B). When serine levels were examined, a significant interaction 
was detected between the effect of time and treatment (F15,23 = 2.76, p 
< 0.05). Both time (F5,23 = 10.89, p < 0.001) and treatment (F3,23 =
5.35, p < 0.01) also had a significant influence on concentration. No 
significant differences were detected between the various exposures at 
the earlier time-points, however, after 24 h, both PFOS (p < 0.05) and 
PFOA (p < 0.001) significantly decreased serine concentrations relative 
to the 0.1 % DMSO control (36 μM and 23 μM versus 57 μM for PFOS and 
PFOA respectively). Alanine concentrations were also measured in 
samples taken at the various time-points. No interaction was found be-
tween the effects of time and treatment on concentration (2-way 
ANOVA), but both time (F5,23 = 8.98, p < 0.001) and treatment (F3,23 =
7.28, p < 0.01) did independently affect the concentration. No signifi-
cant differences were found between concentrations at the earlier time- 
points, whereas after 24 h exposure in both the PFOS and PFOA groups, 
concentrations were significantly increased to 61 and 62 μM, respec-
tively (p < 0.001, for both) compared to 39 μM after exposure to the 0.1 
% DMSO control. 
Fig. 3. Effects of PFOS and PFOA on the glutamate concentration-response 
curve in cerebellar granule neurons (CGNs) at days in vitro (DIV) 14. CGNs 
were exposed for 24 h to increasing concentrations of glutamate (1, 10, 20 or 
100 μM) in conjunction with 5 μM glycine and PFOS (20 μM) or PFOA (300 
μM), before assessment of viability with the MTT assay (n = 4). Glutamate and 
glycine (1, 10, 20, 100, 250 and 500 μM) were also tested alone in all experi-
ments. Abbreviations: Glu = Glutamate. 
Table 1 
EC50 values with 95 % CI from rat CGNs for glutamate/glutamate + PFAA 
concentration-response curves at DIV14.  
Exposure EC50 (μM) EC50 95 % CI 
Glutamate* + 5 μM Glycine 17.9 [10.8,30.8] 
Glutamate* + 5 μM Glycine + 20 μM PFOS 2.3 [0.3,5.1] 
Glutamate* + 5 μM Glycine + 300 μM PFOA 7.8 [3.1,17.1] 
Abbreviations: CGN = Cerebellar granule neuron, PFAA = Perfluoroalkyl acid, 
DIV = Days in vitro. 
* Applied concentrations of glutamate were 1, 10, 20 and 100 μM in the 
presence of PFAAs, and 1, 10, 20, 100, 250 and 500 in their absence. 
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4. Discussion 
In the present study we observed that 24 h exposure of rat CGNs to 
PFOS at DIV 8 caused a concentration-dependent left and downward 
shift of the glutamate concentration-response curve. This enhanced 
toxicity of glutamate was significantly reduced by co-exposure to the 
competitive NMDA-R antagonist CPP. PFOA, on the other hand, had no 
significant effect on glutamate-induced toxicity in cells at this stage of 
maturation. When extracellular glutamate levels were measured after 
PFOS exposure, small non-significant increases were observed at all 
tested time-points, whereas PFOA induced a relatively large increase in 
extracellular glutamate, but only after 24 h. Additionally, at DIV 8, 24 h 
exposure of CGNs to PFOS and PFOA significantly decreased serine 
levels and increased alanine levels in the extracellular environment. In 
CGN exposed to PFOS and PFOA at DIV 14 a parallel left shift of the 
glutamate concentration-response curve was observed for both com-
pounds. In our experiments the applied concentrations of PFOS were 
lower, whereas the concentrations of PFOA were higher, than levels 
reported in occupationally exposed workers. 
When CGNs at DIV 8 were exposed to increasing concentrations of 
Fig. 4. Effects of CPP and PFOS/PFOA on glutamate + glycine-induced toxicity in rat cerebellar granule neurons (CGNs). CGNs were exposed at DIV 8 for 24 h to 5 
μM glycine together with increasing concentrations of glutamate (1, 10, 20, 100, 250 and 500 μM) and viability assessed with the MTT assay (Figure A-F). Addi-
tionally cells were treated with glutamate and glycine in conjunction with 10 μM CPP, 20 μM PFOS, 20 μM PFOS + 10 μM CPP, 300 μM PFOA or 300 μM PFOA + 10 
μM CPP (n = 4 for all). Treatment of cells with 20 μM PFOS or 300 μM PFOA only resulted in viability values at 103 and 88 % of the DMSO control (results not 
displayed). Significant differences between treatment combinations with and without CPP are indicated by*, ** and *** representing p < 0.05, p < 0.01 and p 
< 0.001. 
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glutamate for 24 h, a concentration response curve that plateaued at 100 
μM glutamate demonstrated a maximum reduction of cell viability to 
around 40 % of the DMSO control (Fig. 2). This is in line with previous 
publications (Marini and Paul, 1992; Antkiewicz-Michaluk et al., 2006). 
The lack of complete toxicity after glutamate exposure may be caused by 
the presence of some Mg2+ (0.81 mM MgSO4) in the exposure medium, 
which is known to inhibit NMDA-stimulated calcium signals in a 
concentration-dependent manner (Marini and Novelli, 1991; Chen et al., 
2005). It may also be due to subpopulations of cells in the culture that 
are unresponsive to glutamate. Heterogeneity amongst CGNs in culture 
has been reported (Milani et al., 1993). We have previously shown that 
PFOS induces excitotoxicity in CGNs, which likely involves influx of 
Ca2+ via the NMDA-R, and which may be blocked by specific NMDA-R 
antagonists (Berntsen et al., 2018). In the present study, exposure of 
cells to non- and marginally toxic concentrations of PFOS in addition to 
glutamate caused a downward and left shift of the glutamate 
concentration-response curve indicating enhanced efficacy and potency. 
This effect seemed to be concentration dependent (Fig. 2A). These re-
sults indicate that PFOS is not likely to be acting only directly on the 
orthosteric glutamate binding site of the NMDA-R, but that it may have 
other effects on glutamatergic neurons and/or other cells. One possi-
bility could be an allosteric action on the NMDA-R at a separate site from 
glutamate, potentiating its effects. PFOS is known to have high affinity 
for proteins in general, and previous studies have shown that it tends to 
cluster at specific areas of the cell membrane (Gutleb et al., 2012; 
Berntsen et al., 2017), which could be consistent with areas dense in 
receptors. Binding of PFAAs to neurotransmitter receptors has been 
indicated by others. In a recent study Tukker et al. (2020) showed that 
PFOS and PFOA inhibit human GABAA receptors, with a slow restoration 
of the GABA-evoked current for PFOS as opposed to rapid for PFOA, 
indicating a higher receptor affinity for PFOS compared to PFOA. The 
higher PFOS affinity they assumed could be associated with the func-
tional group. A hypothesis for the mechanism of action was that a 
voltage dependent pore block by PFOS and/or PFOA could be occurring 
through insertion of part of the molecule into the pore of the receptor. 
Tukker et al. (2020) also indicated that PFAAs could potentially be 
acting simultaneously at various kinds of neurotransmitter receptors 
including both glutamate and GABAA receptors. While this was not 
explored in the current study it is well established that glutamate and 
GABA contribute to the excitatory-inhibitory balance in many neural 
systems, so inhibition of GABA would enhance the actions of glutamate. 
Another potential explanation for the observed effects of PFOS on the 
glutamate concentration-response curve, could be effects of PFOS on the 
cell membrane. PFOS has been shown to affect membrane fluidity and 
permeability of cells (Hu et al., 2003) and to be quickly taken up in 
JEG-3 cells, whereas PFOA was absorbed more slowly (Gorrocahtegui 
(2014); a difference that corresponds to our previous observation of a 
difference in the time course of toxicity between the two agents 
(Berntsen et al., 2017). Thus PFOS may have an effect on the cell’s 
membrane potential. Previous studies have shown that a depolarisation 
of CGNs causes toxicity presumptively through the release of glutamate 
from endogenous stores (Schramm et al., 1990). As shown by Día-
z-Trelles et al. (2000) depolarisation of CGNs in culture and glutamate 
release may result from pre-synaptic activation of voltage sensitive so-
dium channels, with the released glutamate subsequently activating 
NMDA-Rs and promoting the synthesis of cyclic(c)GMP (Díaz-Trelles 
et al., 2002) Additionally, activation of L-type voltage dependent cal-
cium channels (L-VDCCs) has been shown necessary for the release of 
sufficient amounts of glutamate to promote NMDA-R-dependent cGMP 
formation and excitotoxicity (Díaz-Trelles et al., 2002). L-VDCCs are 
important for the survival of CGNs in culture, also under basal condi-
tions, due to provision of a trophic influx of calcium and cGMP forma-
tion (Díaz-Trelles et al., 2002). PFOS-induced Ca2+ influx through 
L-VDCCs was observed by Liao et al. (2008) in primary rat hippocampal 
neurons, whereas the involvement of both L-VDCCs and NMDA-Rs were 
involved in the increase of [Ca2+]i, in CGNs after exposure to per-
fluorohexane sulfonic acid (PFHxS), a shorter chained variant of PFOS 
(Lee et al., 2016). In Berntsen et al. (2017) and Berntsen et al. (2018) we 
observed that the toxicity induced by PFOS was rapid, and mirrored the 
toxicity induced by glutamate in another study, where most of the 
Fig. 5. Time-dependent changes in the levels of 
selected amino acids, released to the extracel-
lular space after exposure to PFOS and PFOA. 
Levels of A) glutamate and B) glycine expressed 
as signal response area relative to the area of 
the internal standard Norvaline, as well as 
quantitative values of C) serine and D) alanine 
measured by HPLC-PDA after 30 and 60 min as 
well as 2, 3 and 24 h exposure to 60 μM PFOS, 
500 μM PFOA, 0.1 % DMSO or HBSS buffer only 
(n = 2). Significant differences between the 0.1 
% DMSO control and other treatment groups at 
a certain time-point are indicated with * and 
*** representing p < 0.05 and p < 0.001, 
respectively.   
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toxicity occurred within 3 h (Ankarcrona et al., 1995). In addition to 
resulting in release of endogenous glutamate, a potential depolarisation 
could have increased the cell’s responsiveness to glutamate due to 
removal of more of the voltage dependent Mg2+ block. However, 
whether this is the case would have to be confirmed through electro-
physiological studies. An increase in levels of cGMP after glutamate 
stimulation has previously been described in CGNs cultured in the 
absence of Mg2+ or under depolarising conditions (Novelli et al., 1987). 
Another factor that should be taken into account is that PFOS and 
PFOA were dissolved in DMSO. Although the concentration of DMSO 
was not higher than 0.1 %, and by itself was not observed to induce any 
effects on cell viability, DMSO is known for entering cell membranes 
(Jacob et al., 1964a, b; de Ménorval et al., 2012), and may have facili-
tated access of PFOS to the intracellular space, although Makarewicz 
et al. (2003) reported that DMSO in concentrations 0.06–1.11 %, did not 
affect NMDA-induced calcium uptake in CGNs and de Ménorval et al. 
(2012) reported no permeabilisation of the cell membrane up to 15 Vol 
% DMSO. 
When amino acid levels in the extracellular environment were 
investigated, a 9–13 fold increase in glutamate levels as compared to the 
0.1 % DMSO control was observed after 1− 3 h, as well as after 24 h 
exposure to PFOS, although the results are not statistically significant 
due to the small number of samples analysed (Fig. 5A). However, as the 
LOQ for glutamate for the applied detection method was relatively high 
(25 μM) it was not possible to accurately quantify these increases. It is 
unlikely, however, that the amount of glutamate released would exceed 
25 μM. In comparison, glutamate levels in buffer from CGNs exposed for 
3 h have, in a previous study, been reported to be non-detectable for 
DMSO, and up to 10 μM for cells exposed to another halogenated 
compound, tetrabromobisphenol A (TBBPA) (Reistad et al., 2007). In 
support of our findings, PFOS has previously been observed to increase 
endogenous glutamate in the hippocampus of mice orally exposed to 
PFOS (Long et al., 2013) and to increase extracellular glutamate in 
cultures of rat primary cortical astrocytes (Li et al., 2017). Although 
some glutamate release was detected in the present experiment, this is 
not likely to be the sole explanation for the enhancement of glutamate 
toxicity by PFOS. Even at the highest tested concentration of glutamate 
(500 μM) a significant toxicity potentiation was observed (Fig. 2A), and 
the amount of glutamate released as a result of PFOS exposure is highly 
unlikely to contribute to the increase in toxicity induced by 500 μM 
glutamate. Another interesting observation is that a maximum increase 
in glutamate after PFOS exposure, is not immediately detectable 
(Fig. 5A), and may thus also be a result of a toxic or sub-toxic excito-
toxicity independent process, at least at the concentrations of PFOS 
applied. As synaptic glutamate release from cerebellar granule cells is 
known to occur in a Ca2+ dependent manner (Gallo et al., 1982), 
possible interesting future studies would be to assess whether 
PFOS-induced glutamate release is enhanced in the presence of a cal-
cium ionophore, such as described by Thomas et al. (1989). In contrast 
to PFOS, exposure to PFOA on DIV 8 did not significantly affect the 
glutamate concentration-response curve (Fig. 2B), neither did it induce 
glutamate release, with the exception of the 24 h exposure, where a 
relatively large and significant 80-fold increase was observed (Fig. 5A). 
This is consistent with previous studies in which PFOA did not induce 
rapid excitotoxicity, nor was it able to acutely increase levels of Ca2+, 
even at very high concentrations. The induced toxicity was slower than 
the PFOS-induced toxicity, and indicated a possible different mechanism 
of action from that of PFOS (Berntsen et al., 2017, 2018). 
In the present study we did not measure [Ca2+]i. However, in 
Berntsen et al. (2018) an increase in [Ca2+]i, was observed after 30 and 
60 min exposure to 60, 100 and 300 μM PFOS (only statistically sig-
nificant from the control at 300 μM), which at 300 μM was completely 
blocked by the non-competitive NMDA-R open channel blocker MK-801. 
Although the lower concentrations of PFOS presently applied were not 
toxic on their own, there is a possibility that excitotoxicity produced by 
the association of a subtoxic concentration of PFOS (or PFOA) to the 
glutamate-induced toxicity may be due to a toxicologically significant 
increase in [Ca2+]i. As is well established, Ca2+i may be involved both in 
physiological second messenger systems and in toxic processes 
depending on concentration. In CGNs it has been shown that after 
approximately 3 days in culture depolarisation-induced Ca2+ influx 
leading to the activation of Ca2+/calmodulin-dependent protein kinases, 
is necessary for the maintenance of healthy cells, mimicking the physi-
ological stimulation of excitatory amino acid receptors occurring in vivo 
by mossy fibers (Gallo et al., 1987). As primary cultures of CGNs 
differentiate in culture they undergo morphological, physiological and 
biochemical differentiation (Gallo et al., 1982; Novelli and Henneberry, 
1987; Thomas et al., 1989) and acquire the capability to increase the 
synthesis of cGMP in response to stimulation by excitatory amino acids, 
which is dependent on calcium influx (Novelli and Henneberry, 1987). 
CGNs in culture are able to synthesis glutamate from glutamine by the 
aid of the enzyme glutaminase (Thomas et al., 1989). With time in 
culture the CGNs develop the capability of releasing glutamate in a 
Ca2+-dependent manner after a depolarising stimulus (Gallo et al., 
1982). This release of glutamate is paralleled by the induction of 
glutaminase as well as the formation of neurites, synaptic vesicles and 
synapses (Thomas et al., 1989). Further, the electrophysiological prop-
erties of CGNs have also been found to change with increasing age of the 
culture (Galdzicki et al., 1991). In a previous study, the toxicity of PFOS 
in CGNs also seemed to be dependent on the developmental stage of the 
culture, as exposure of cells at DIV 0 for 8 days, in contrast to exposure at 
DIV 8 or 14 has no effects on viability (Berntsen et al., 2018). 
When CGNs were exposed to either glutamate/glycine alone or to 
glutamate/glycine + PFOS in conjunction with the competitive NMDA-R 
antagonist CPP, cell viability was significantly improved. Concentra-
tions at or above 100 μM glutamate alone were significantly antagon-
ised, but in combination with PFOS viability was improved at 
concentrations of 10 μM and above (Fig. 4). Interestingly, as may also be 
observed from Fig. 4, at concentrations up to 100 μM the protective 
effect of CPP treatment seemed to be higher in the presence of PFOS, 
than for cells treated with glutamate alone. This may reflect the fact that 
glutamate induces additional toxicity through other receptors. Another 
possibility is that PFOS induces a conformational change in the receptor 
that increases the affinity for CPP but that is speculative at this time. 
As opposed to exposure at DIV 8, exposure of CGNs at DIV 14 to PFOS 
in conjunction with glutamate caused a leftward (i.e. increased po-
tency), but not a downward, shift of the glutamate concentration- 
response curve (Fig. 3). In cells at this stage of maturation, the 
maximum toxicity reached by glutamate alone was also somewhat 
higher, which could have contributed to these differences. Cells at DIV 
14 are known to express more mature NMDA-Rs with an increased 
number of GluN2C subunits as compared to cells at DIV 8. As receptors 
containing these subunits are assumed to have higher affinity for 
glutamate and have a reduced sensitivity to voltage dependent Mg2+
block (Vallano et al., 1996), this may explain the somewhat higher 
toxicity for glutamate observed at DIV 14. This is however only specu-
lative at present, and would have to be confirmed by supplementary 
studies in Mg2+ free-medium. CGNs in the present study were grown 
under partially depolarising conditions (25 mM) necessary for the 
maintenance of some Ca2+ influx (Gallo et al., 1987), and required for 
the survival of cells in culture. It has been shown, that at DIV 8 depo-
larisation of CGNs or the absence of Mg2+ from the extracellular envi-
ronment is necessary for the coupling of activation of NMDA-Rs by 
glutamate with guanylate cyclase and an increase in cGMP (Novelli 
et al., 1987). Further, Novelli et al. (1988) suggested that maintenance 
of the resting membrane potential and voltage-dependent Mg2+ block of 
the NMDA-R channel is dependent on glucose metabolism, ATP pro-
duction and a functioning Na+,K+-ATPase. Under conditions of energy 
depletion, and relief of the NMDA-R Mg2+ block, glutamate starts acting 
as a neurotoxin, even at low concentrations, causing persistent activa-
tion of NMDA-Rs, opening of ion channels, and neuronal damage 
(Novelli et al., 1988). To compensate for energy loss CGNs are usually 
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cultured in the presence of glucose, and for long term cultures glucose 
was in the present study added repeatedly as previously described by 
others (Novelli et al., 1988; Schramm et al., 1990; Fernández et al., 
1991; Galdzicki et al., 1991; de Luca et al., 1996). The lack of effects of 
PFOA exposure on the glutamate concentration-response curve at DIV 8 
(Fig. 2B) were in contrast to DIV 14 where PFOA, in a similar manner to 
PFOS, caused a left shift of the glutamate curve (Fig. 3), which may also 
reflect changes in receptor subunits. Interestingly, in our previous study 
we found that the competitive NMDA-R antagonist CPP did provide 
some protection against PFOA-induced toxicity in mature cells exposed 
at DIV 14, as compared to cells exposed at DIV 8, where no such effect 
could be observed. This effect on PFOA-induced toxicity was not, how-
ever, replicated by the use of the open channel blockers MK-801or 
memantine (Berntsen et al., 2018). 
Another interesting finding from the amino acid measurements was 
that serine and alanine levels were significantly different in cells 
exposed to PFOS and PFOA when compared to control experiments at 
later time points (Fig. 5C and D). During the last years it has been 
demonstrated that D-serine modulates NMDA-R function and regulates 
synaptic plasticity, neurodevelopment, as well as learning and memory 
processes (Wolosker et al., 2016) and can act as a co-agonist of NMDA-R 
in a similar manner to glycine (Wolosker et al., 2016). D-serine is syn-
thesised in neurons by the enzyme serine racemase from L-serine and 
catabolized by D-amino acid oxidase (DAAO) in astrocytes. Rosenberg 
et al. (2013) demonstrated that D-serine release in the synaptic cleft 
occurs by the neuronal alanine-serine-cysteine transporter 1 (ASC-1), a 
plasma membrane antiporter that mediates tonic D-serine release. In 
line with this new paradigm, our results are showing a significant 
decrease of extracellular D-serine values in exposure bufferfrom cultures 
treated with PFOS and PFOA and a corresponding increase of alanine in 
these same cultures. This could indicate an activation of the ASC-1 
transporter in CGNs and the elimination of the serine pool from the 
synaptic cleft. It is then expected that these neurochemical effects on 
serine levels, observed 24 h after exposure and coinciding with the in-
crease in extracellular glutamate levels, may have an effect on the 
modulation of NMDA-R function. Confirming our findings, a newly 
published study has shown that PFOS-induced disruption of D-serine 
homeostasis in astrocytes affects the expression of NMDA-Rs in rat pri-
mary hippocampal neurons and leads to neurotoxicity (Wang et al., 
2019). 
4.1. Limitations 
Although we believe our data clearly demonstrate potentiation of 
glutamate excitotoxicity by PFAAs the mechanism(s) by which this oc-
curs are still unclear. Future experiments that could better identify such 
mechanisms include studies in Mg2+-free media and the use of calcium 
entry blockers. Further, measures of glutaminase activity, as well as 
other key enzymes involved in glutamatergic signaling in CGNs exposed 
to PFAAs could help to understand if the metabolic state of the cultures 
is altered. Lastly although our quantitation of glutamate release sug-
gested substantial increases, the result is inconclusive because the 
method used lacked sufficient sensitivity. Repeating these experiments 
using a more sensitive detection method is warranted. 
5. Conclusion 
In the present study we have found that PFOS induced a 
concentration-dependent left and downward shift of the glutamate 
concentration-response curve, even at a concentration of PFOS that was 
not by itself cytotoxic. This indicates that PFOS excitotoxicity may 
involve potentiation of glutamate signaling via an allosteric action on 
the NMDA-R or an action on other elements regulating glutamate release 
or otherwise affecting NMDA-R signalling. Small, non-significant in-
creases of glutamate after 1, 2, 3 and 24 h exposure to PFOS, as opposed 
to a large increase in glutamate release only after 24 h exposure to 
PFOA, as well as differences in the response to the antagonist CPP, 
support the possibility that equipotent concentrations of PFOS and 
PFOA may be inducing cellular toxicity via different mechanisms. In 
mature cells at DIV 14 both PFOS and PFOA caused a left shift of the 
glutamate concentration-response curve without a change in efficacy. 
We conclude that interactions between glutamate and the perfluoroalkyl 
toxicants PFOS and PFOA in CGNs are complex and may vary depending 
on the developmental state of the cultures. 
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